Survival Rate and Predictors of Mortality Among TB-HIV Co-Infected Patients During Tuberculosis Treatment at Public Health Facilities in Bahir Dar City, Northwest Ethiopia
Survival Rate and Predictors of Mortality Among TB-HIV Co-Infected Patients During Tuberculosis Treatment at Public Health Facilities in Bahir Dar City, Northwest Ethiopia
By: Teshager Worku Kegne, Zelalem Alamrew Anteneh, Tadios Lidetu Bayeh, Birhanu Melaku Shiferaw, and Desiyalew Habtamu Tamiru
Publication: Infection and Drug Resistance; 9 April 2024. DOI: https://doi.org/10.2147/IDR.S446020
Tuberculosis and human immunodeficiency virus (TB-HIV) co-infection pose a major public health concern in developing countries, with insufficient studies on mortality predictors among co-infected patients in Ethiopia. This study investigated the survival rate and mortality predictors among 401 TB-HIV co-infected patients treated between July 2018 and June 2022 at public health facilities in Bahir Dar, Northwest Ethiopia. Data were collected from patient charts and analyzed using EpiData 3.1 and Stata version 15, with a Cox proportional hazard regression model identifying predictors of mortality. Findings indicated high mortality rates among TB-HIV co-infected patients, highlighting the need to enhance nutritional status, adherence to TB treatment, and prevention of opportunistic infections to improve survival.